Nephros Inc
(NEPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,026 | -6,337 | -26,356 | -8,013 | -5,468 |
| Depreciation Amortization | 231 | 447 | 5,900 | 354 | 306 |
| Accounts receivable | -220 | 1 | -154 | 59 | -133 |
| Other Working Capital | -943 | 10 | 19 | -163 | 289 |
| Other Operating Activity | 346 | 154 | 14,149 | 463 | -97 |
| Operating Cash Flow | $-2,612 | $-5,725 | $-6,442 | $-7,300 | $-5,104 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7 | 4,693 | -1,900 | 1,700 | 1,500 |
| PPE Investments | -28 | -94 | -145 | -110 | -397 |
| Investing Cash Flow | $-21 | $4,599 | $-2,045 | $1,590 | $1,103 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 12,677 | 5,200 | N/A |
| Common Stock Issued | 1,336 | N/A | N/A | 1 | 1,003 |
| Other Financing Activity | 0 | 0 | -992 | 0 | 0 |
| Financing Cash Flow | $1,336 | $N/A | $11,685 | $5,201 | $1,003 |
| Exchange Rate Effect | -5 | -17 | -2 | 15 | 26 |
| Beginning Cash Position | 2,306 | 3,449 | 253 | 747 | 3,719 |
| End Cash Position | 1,004 | 2,306 | 3,449 | 253 | 747 |
| Net Cash Flow | $-1,302 | $-1,143 | $3,196 | $-494 | $-2,973 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,612 | -5,725 | -6,442 | -7,300 | -5,104 |
| Capital Expenditure | -28 | -97 | -145 | -110 | -397 |
| Free Cash Flow | -2,640 | -5,822 | -6,587 | -7,410 | -5,501 |